platinum has been researched along with curcumin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, HS; Su, CL; Wang, YT | 1 |
| Arzuman, L; Beale, P; Huq, F; Yu, JQ | 2 |
| de Souza, P; Scarano, W; Stenzel, MH | 1 |
| Jing, X; Kang, X; Qi, R; Wang, Z; Yan, L; Zhao, C | 1 |
| Basu, U; Chakravarty, AR; Kondaiah, P; Mitra, K; Raza, MK; Shettar, A | 1 |
| Wang, K; Xia, Y; Yu, X; Yuan, L; Zhu, N | 1 |
| Caballero, AB; Censi, V; Dell'Anna, MM; Gamez, P; Korrodi-Gregório, L; Mastrorilli, P; Pérez-Hernández, M; Pérez-Tomás, R; Soto-Cerrato, V | 1 |
8 other study(ies) available for platinum and curcumin
| Article | Year |
|---|---|
Curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves downregulation of nuclear endonuclease G and NF-κB as well as induction of apoptosis and G2/M arrest.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cisplatin; Curcuma; Curcumin; Down-Regulation; Drug Synergism; Endodeoxyribonucleases; HT29 Cells; Humans; NF-kappa B; Organoplatinum Compounds; Phytotherapy; Plant Extracts; Platinum | 2014 |
Monofunctional Platinum-containing Pyridine-based Ligand Acts Synergistically in Combination with the Phytochemicals Curcumin and Quercetin in Human Ovarian Tumour Models.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Curcumin; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Ovarian Neoplasms; Phytochemicals; Platinum; Pyridines; Quercetin | 2015 |
Dual-drug delivery of curcumin and platinum drugs in polymeric micelles enhances the synergistic effects: a double act for the treatment of multidrug-resistant cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Curcumin; Drug Carriers; Drug Delivery Systems; Drug Resistance, Neoplasm; Female; Humans; Micelles; Ovarian Neoplasms; Platinum; Polymers | 2015 |
Synthesis of tris(quinoline)monochloroplatinum(II) Chloride and its Activity Alone and in Combination with Capsaicin and Curcumin in Human Ovarian Cancer Cell Lines.
Topics: Antineoplastic Agents; Capsaicin; Cell Line, Tumor; Curcumin; DNA; Drug Synergism; Female; Humans; Organoplatinum Compounds; Ovarian Neoplasms; Platinum | 2016 |
Sensitizing nanoparticle based platinum(IV) drugs by curcumin for better chemotherapy.
Topics: Cell Line, Tumor; Cell Survival; Cisplatin; Curcumin; Drug Resistance, Neoplasm; Humans; Nanoparticles; Platinum | 2016 |
Photoactive platinum(ii) β-diketonates as dual action anticancer agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Line; Curcumin; DNA; DNA Cleavage; Humans; Light; Platinum; Reactive Oxygen Species | 2016 |
Fabrication of antimicrobial curcumin stabilized platinum nanoparticles and their anti-liver fibrosis activity for potential use in nursing care.
Topics: Animals; Anti-Infective Agents; Cell Survival; Curcumin; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydrogen-Ion Concentration; Liver Cirrhosis; Metal Nanoparticles; Mice; Microscopy, Electron, Transmission; NIH 3T3 Cells; Platinum; Spectroscopy, Fourier Transform Infrared | 2019 |
DNA-binding and in vitro cytotoxic activity of platinum(II) complexes of curcumin and caffeine.
Topics: Animals; Antineoplastic Agents; Caffeine; Cattle; Cell Line, Tumor; Cisplatin; Coordination Complexes; Curcumin; DNA; Drug Screening Assays, Antitumor; Drug Stability; Humans; Ligands; Molecular Structure; Platinum | 2019 |